Diversify Wealth Management LLC lessened its position in MetLife, Inc. (NYSE:MET – Free Report) by 4.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,715 shares of the financial services provider’s stock after selling 386 shares during the quarter. Diversify Wealth Management LLC’s holdings in MetLife were worth $619,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in MET. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of MetLife by 2.0% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 11,297 shares of the financial services provider’s stock worth $793,000 after buying an additional 220 shares during the period. Sei Investments Co. increased its position in shares of MetLife by 20.3% during the 2nd quarter. Sei Investments Co. now owns 411,610 shares of the financial services provider’s stock worth $28,888,000 after purchasing an additional 69,553 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its position in shares of MetLife by 314.8% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 29,553 shares of the financial services provider’s stock worth $2,074,000 after purchasing an additional 22,428 shares in the last quarter. ProShare Advisors LLC increased its position in MetLife by 0.5% in the 2nd quarter. ProShare Advisors LLC now owns 125,806 shares of the financial services provider’s stock valued at $8,830,000 after acquiring an additional 608 shares in the last quarter. Finally, Frank Rimerman Advisors LLC grew its position in shares of MetLife by 4,706.4% during the 2nd quarter. Frank Rimerman Advisors LLC now owns 4,518 shares of the financial services provider’s stock worth $317,000 after buying an additional 4,424 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Stock Performance
NYSE MET opened at $86.88 on Wednesday. The company has a fifty day simple moving average of $83.51 and a 200 day simple moving average of $79.66. MetLife, Inc. has a 12-month low of $64.61 and a 12-month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a market cap of $60.16 billion, a P/E ratio of 17.52, a PEG ratio of 0.64 and a beta of 1.07.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
MET has been the topic of several recent analyst reports. Piper Sandler lifted their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Jefferies Financial Group boosted their target price on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. JPMorgan Chase & Co. upped their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Finally, Barclays raised their price objective on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.92.
Read Our Latest Stock Analysis on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Which Wall Street Analysts are the Most Accurate?
- SAP’s Strong Momentum: A Bullish Setup for Investors
- 3 Warren Buffett Stocks to Buy Now
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.